PBYI
Puma BiotechnologyBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PBYI vs peer average
69/100
PBYI vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
GLSI is the first available peer comparator.
Greenwich LifeSciences is a closer thematic breast-cancer comparator, but it remains much earlier stage than Puma's commercial NERLYNX base, so it is more a sentiment and event-volatility comp than a direct operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PBYI
Puma Biotechnology
GLSI
Greenwich LifeSciences
Grade
B
C
Momentum
70
5
Value
70
41
Sentiment
28
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs GLSI
PBYI / GLSI
Grade Position
In line
PBYI vs. peer average (B vs. C)
69/100
Momentum
70
PBYIValue
70
PBYISentiment
28
GLSIRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PBYI
GLSI is the first peer returned for this comparison set.